Drugs to undergo their efficacy equivalence test will benefit from the insurance coverage

The MOHW has announced that of the items whose application for the drug efficacy equivalence tests was already submitted to the Korea Food and Drug Administration (KFDA), any items will be excluded the current list of insurance-covered drugs from August 1 this year, unless otherwise approved by July 20.

The KFDA said that a total of items with proven drug efficacy equivalence based on the co...